Centre for the Economics of Mental and Physical Health (CEMPH), Institute of Psychiatry, King's College London, London, UK.
BMC Health Serv Res. 2012 Aug 20;12:264. doi: 10.1186/1472-6963-12-264.
Fatigue is common and has been shown to result in high economic costs to society. The aim of this study is to compare the cost-effectiveness of two active therapies, graded-exercise (GET) and counselling (COUN) with usual care plus a self-help booklet (BUC) for people presenting with chronic fatigue.
A randomised controlled trial was conducted with participants consulting for fatigue of over three months' duration recruited from 31 general practices in South East England and allocated to one of three arms. Outcomes and use of services were assessed at 6-month follow-up. The main outcome measure used in the economic evaluation was clinically significant improvements in fatigue, measured using the Chalder fatigue scale. Cost-effectiveness was assessed using the net-benefit approach and cost-effectiveness acceptability curves.
Full economic and outcome data at six months were available for 163 participants; GET = 51, COUN = 58 and BUC = 54. Those receiving the active therapies (GET and COUN) had more contacts with care professionals and therefore higher costs, these differences being statistically significant. COUN was more expensive and less effective than the other two therapies. The incremental cost-effectiveness ratio of GET compared to BUC was equal to £987 per unit of clinically significant improvement. However, there was much uncertainty around this result.
This study does not provide a clear recommendation about which therapeutic option to adopt, based on efficiency, for patients with chronic fatigue. It suggests that COUN is not cost-effective, but it is unclear whether GET represents value for money compared to BUC. Clinical Trial Registration number at ISRCTN register: 72136156.
疲劳是常见的,已经表明它会给社会带来高昂的经济成本。本研究的目的是比较两种积极治疗方法,即分级运动(GET)和咨询(COUN)与常规护理加自助手册(BUC)对慢性疲劳患者的成本效益。
一项随机对照试验在英格兰东南部的 31 家普通诊所招募了患有慢性疲劳超过三个月的患者,并将他们随机分配到三个治疗组之一。在 6 个月的随访中评估了结果和服务的使用情况。经济评估中使用的主要结果测量是用 Chalder 疲劳量表测量的疲劳的临床显著改善。使用净效益方法和成本效益可接受性曲线评估成本效益。
163 名参与者在 6 个月时获得了完整的经济和结果数据;GET=51,COUN=58,BUC=54。接受积极治疗(GET 和 COUN)的患者与护理专业人员的接触更多,因此成本更高,这些差异具有统计学意义。COUN 比其他两种疗法更昂贵且效果更差。与 BUC 相比,GET 的增量成本效益比等于每单位临床显著改善的 987 英镑。然而,这个结果存在很大的不确定性。
本研究没有根据效率为慢性疲劳患者提供明确的治疗选择建议。它表明 COUN 不具有成本效益,但尚不清楚 GET 是否比 BUC 更具性价比。临床试验注册号在 ISRCTN 注册:72136156。